67.00EUR-0.15%Mkt Cap: 9.54B EURP/E: 18.01Last update: 2026-05-13
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)18.01
P/E (Forward)—
PEG5.73
P/B8.50
P/S4.88
EV/EBITDA13.41
EV/Revenue4.95
EPS (TTM)3.76
EPS (Forward)—
Cash Flow & Leverage
FCF Yield3.44%
FCF Margin16.81%
Operating CF316.80M EUR
CapEx (TTM)97.60M EUR
Net Debt/EBITDA0.18
Net Debt131.00M EUR
Technical
SMA 5069.58 (-3.7%)
SMA 20066.54 (+0.7%)
Beta0.27
S&P 52W Chg24.23%
Avg Vol (30d)9.28K
Avg Vol (10d)7.23K
Technical Indicators
RSI (14)41.2
MACD-0.7892
MACD Signal-0.4714
MACD Hist.-0.3178
BB Upper75.72 EUR
BB Middle69.80 EUR
BB Lower63.88 EUR
BB Width16.97%
ATR (14)1.819 EUR
Vol Ratio (20d)0.70x
52W Range
51.6066% of range75.10
52W High75.10 EUR
52W Low51.60 EUR
Profitability
Gross Margin64.20%
EBITDA Margin36.91%
Profit Margin26.48%
Oper. Margin27.46%
ROE38.95%
ROA24.89%
Revenue Growth17.80%
Earnings Growth46.70%
Balance Sheet
Debt/Equity0.24
Current Ratio1.77
Quick Ratio1.13
Book Value/Sh7.968 EUR
Cash/Share1.415 EUR
Dividends
Fwd Div Rate1.800 EUR
Trail. Div Rate1.800 EUR
Div. Yield2.66%
5Y Avg Yield3.32%
Payout Ratio45.74%
Ex-Div DateOct 19, 2026
Pay Date—
Ownership
Shares Out.31.52M
Float123.11M
Insiders32.50%
Institutions7.96%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap9.54B EUR
Enterprise Value9.67B EUR
Revenue (TTM)1.95B EUR
Gross Profit1.21B EUR
Net Income (TTM)500.30M EUR
Revenue/Share13.88 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.1K
Last Price67.00 EUR
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377